ClinCapture announces AI-powered clinical trial build tech that automates study configuration, and advances intelligent ...

Led by researchers at NDORMS as part of the Data Analysis and Real World Interrogation Network (DARWIN EU) initiative, a new ...

Clinical research has always been the backbone of medical progress, providing the data and insights needed to develop new ...

Company's Latest Solution Integrates Protocol Design, Document Generation, and Statistical Programming to Accelerate Trial Execution and Deliver Submission-ready Data "AI Conductor transforms clinical ...

The Phase III study FIND-CKD ( NCT05047263) — investigating the efficacy and safety of KERENDIA ® (finerenone) versus placebo when added to standard of care in adult patients with non-diabetic chronic ...

BERKELEY HEIGHTS, N.J., Oct. 23, 2024 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; "Cyclacel" or the "Company"), a ...

The company aims to start a pivotal trial this year, file for 510(k) clearance in 2027 and launch the device in 2028.

“Our partnership with CRIO accelerates our strategy connecting site-level eSource and the Medidata Platform,” said Tom Doyle, chief technology officer, Medidata. “This will accelerate workflows for ...

Placebo-adjusted mean weight loss of 16.3% (39 lbs) at 180 mg and 16.0% (37 lbs) at 240 mg at 44 weeks with no evidence of weight loss plateau in ...

A growing body of research into Parkinson’s disease is challenging the assumption that the condition looks the same in every ...

Positive data from EXPERTS-ALS could accelerate RT1999 towards a registration trial; RT1999 to be presented as a poster ...

NS002 demonstrated significantly faster time to the critical 100 pg/mL epinephrine threshold compared to EpiPen®, with a ...